Ganga Pharmaceuticals financials at a glance
| Year | Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
26.29M | 30.10M | 30.53M | 33.63M | 30.79M | 23.74M | 24.89M | 0.00M | 0.00M | 0.00M |
| GM % | Gross Margin % |
|
57.47% | 63.85% | 61.90% | 62.07% | 56.69% | 47.61% | 48.73% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
9.91% | 8.84% | 8.60% | 10.88% | 10.79% | -0.95% | -0.51% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
0.00 | 0.00 | ||||||||
| Div. | Dividends |
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
0m | 4.06m | 4.06m | 4.06m | 4.06m | 4.06m | 4.06m | 4.06m | 0m | 0m |
| OCF | Operating Cash Flow |
|
-10.54M | 0.46M | 2.37M | 1.13M | -3.06M | -1.75M | -1.97M | 0.00M | 0.00M | 0.00M |
| FCF | Free Cash Flow |
|
-10.64M | 0.06M | -0.26M | 0.81M | -3.16M | -1.92M | -2.12M | 0.00M | 0.00M | 0.00M |
| FCFS | Free Cash Flow Per Share |
|
-2.62 | 0.01 | -0.06 | 0.20 | -0.78 | -0.47 | -0.50 | 0.00 | 0.00 | 0.00 |